Neuronetics Inc (STIM)

$1.45 -0.07 (-4.29%)
Market Cap 92.46M
Revenue (ttm) 74.89M
Net Income (ttm) -43.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -58.37%
Debt to Equity Ratio 2.09
Volume 2,028,600
Avg Vol 2,145,136
Day's Range N/A - N/A
Shares Out 68.49M
Stochastic %K 88%
Beta 0.87
Analysts Strong Sell
Price Target $4.33

Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 640 4202
Fax: 610 640 4206
Address:
3222 Phoenixville Pike, Malvern, United States
mantegnous
mantegnous Mar. 20 at 1:07 PM
$STIM 👀👀👀👀
0 · Reply
FilingTracker
FilingTracker Mar. 20 at 12:53 PM
$STIM Insider purchase: https://www.sec.gov/Archives/edgar/data/1227636/000092189526000751/xslF345X06/form414528003sti_03202026.xml
0 · Reply
mantegnous
mantegnous Mar. 19 at 8:00 PM
$STIM going to cross the SMAs?!
0 · Reply
mantegnous
mantegnous Mar. 19 at 7:33 PM
$STIM uhm
0 · Reply
anachartanalyst
anachartanalyst Mar. 19 at 7:02 PM
$STIM https://anachart.com/wp-content/uploads/ana_temp/1773946931_soc-img.jpg
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 18 at 2:37 PM
FORM 4P $STIM - Neuronetics, Inc.* 10% OWNER: Chernett Jorey P | 531,000 | $1.16 | $615,960
0 · Reply
SellHoldBuy
SellHoldBuy Mar. 17 at 6:41 PM
$STIM New ceo looks strong. This will go up. Weird day after positive results.
0 · Reply
Dou_said_it
Dou_said_it Mar. 17 at 4:06 PM
$STIM i don t know what tondo in yhis case lol: Hold because good results / Sell because Shorts and it can go down soon
0 · Reply
ejz92
ejz92 Mar. 17 at 2:25 PM
$STIM Easy money on manipulated drop. Let’s burn the shorts!
0 · Reply
1SwingSensei
1SwingSensei Mar. 17 at 2:06 PM
$STIM Outrageous head fake, deep red to green. If you're not bullish & or didn’t buy the dip, shame on you!🫠
1 · Reply
Latest News on STIM
Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript

Mar 17, 2026, 1:12 PM EDT - 4 days ago

Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript

Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 17, 2026, 7:50 AM EDT - 4 days ago

Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

Mar 17, 2026, 7:45 AM EDT - 4 days ago

Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Feb 10, 2026, 4:34 PM EST - 5 weeks ago

Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 8:30 AM EST - 4 months ago

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

Nov 18, 2025, 6:40 AM EST - 4 months ago

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

AIRS NOTV

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Nov 12, 2025, 10:33 AM EST - 4 months ago

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 12:26 PM EST - 4 months ago

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Nov 4, 2025, 7:05 AM EST - 4 months ago

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 31, 2025, 4:30 PM EDT - 5 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

Oct 30, 2025, 8:32 AM EDT - 5 months ago

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Oct 21, 2025, 8:30 AM EDT - 5 months ago

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Sep 17, 2025, 8:32 AM EDT - 6 months ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:53 PM EDT - 8 months ago

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 4, 2025, 4:30 PM EDT - 8 months ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Jul 30, 2025, 8:32 AM EDT - 8 months ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Neuronetics Appoints New Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 8 months ago

Neuronetics Appoints New Chief Financial Officer

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Jun 10, 2025, 8:31 AM EDT - 10 months ago

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Jun 2, 2025, 4:30 PM EDT - 10 months ago

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:57 AM EDT - 11 months ago

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

Neuronetics Reports First Quarter 2025 Financial and Operating Results

May 6, 2025, 7:10 AM EDT - 11 months ago

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Mar 31, 2025, 8:31 AM EDT - 1 year ago

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Mar 29, 2025, 11:45 PM EDT - 1 year ago

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 9:52 AM EST - 1 year ago

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 7:10 AM EST - 1 year ago

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Feb 7, 2025, 7:54 AM EST - 1 year ago

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

Feb 6, 2025, 4:23 PM EST - 1 year ago

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Jan 29, 2025, 8:31 AM EST - 1 year ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 1 year ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 8:30 AM EST - 1 year ago

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 1 year ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 6:45 PM EST - 1 year ago

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:10 AM EST - 1 year ago

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

Oct 29, 2024, 4:30 PM EDT - 1 year ago

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Oct 14, 2024, 8:31 AM EDT - 1 year ago

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Oct 4, 2024, 8:33 AM EDT - 1 year ago

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Sep 25, 2024, 8:31 AM EDT - 1 year ago

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

Sep 19, 2024, 8:31 AM EDT - 1 year ago

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

NeuroStar® Releases Software Upgrades to Elevate Patient Care

Sep 16, 2024, 8:32 AM EDT - 1 year ago

NeuroStar® Releases Software Upgrades to Elevate Patient Care

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Sep 3, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Aug 12, 2024, 1:12 PM EDT - 1 year ago

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024, 7:15 AM EDT - 1 year ago

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 7:10 AM EDT - 1 year ago

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Aug 1, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

Jul 22, 2024, 8:31 AM EDT - 1 year ago

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

Jul 11, 2024, 8:36 AM EDT - 1 year ago

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

mantegnous
mantegnous Mar. 20 at 1:07 PM
$STIM 👀👀👀👀
0 · Reply
FilingTracker
FilingTracker Mar. 20 at 12:53 PM
$STIM Insider purchase: https://www.sec.gov/Archives/edgar/data/1227636/000092189526000751/xslF345X06/form414528003sti_03202026.xml
0 · Reply
mantegnous
mantegnous Mar. 19 at 8:00 PM
$STIM going to cross the SMAs?!
0 · Reply
mantegnous
mantegnous Mar. 19 at 7:33 PM
$STIM uhm
0 · Reply
anachartanalyst
anachartanalyst Mar. 19 at 7:02 PM
$STIM https://anachart.com/wp-content/uploads/ana_temp/1773946931_soc-img.jpg
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 18 at 2:37 PM
FORM 4P $STIM - Neuronetics, Inc.* 10% OWNER: Chernett Jorey P | 531,000 | $1.16 | $615,960
0 · Reply
SellHoldBuy
SellHoldBuy Mar. 17 at 6:41 PM
$STIM New ceo looks strong. This will go up. Weird day after positive results.
0 · Reply
Dou_said_it
Dou_said_it Mar. 17 at 4:06 PM
$STIM i don t know what tondo in yhis case lol: Hold because good results / Sell because Shorts and it can go down soon
0 · Reply
ejz92
ejz92 Mar. 17 at 2:25 PM
$STIM Easy money on manipulated drop. Let’s burn the shorts!
0 · Reply
1SwingSensei
1SwingSensei Mar. 17 at 2:06 PM
$STIM Outrageous head fake, deep red to green. If you're not bullish & or didn’t buy the dip, shame on you!🫠
1 · Reply
Fillorkill7
Fillorkill7 Mar. 17 at 1:59 PM
$STIM imagine being short one of the most shorted name on the planet and it opens down 25%, and it finishes the day up 100%. Could be fun to watch. $GME $AMC $BYND $OPEN
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:46 PM
$STIM HOLDING AND PUSHING!
1 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:42 PM
$STIM
0 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:41 PM
$STIM they threw it down over 40 %, lol so iliquid
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:38 PM
$STIM SICKNING
0 · Reply
ejz92
ejz92 Mar. 17 at 1:38 PM
$STIM WTH?? Numbers were not that bad?
0 · Reply
RedLeader2
RedLeader2 Mar. 17 at 1:37 PM
$STIM the short selling shit is just ruining the market for everyone
0 · Reply
Davidoct1405
Davidoct1405 Mar. 17 at 1:23 PM
$STIM clearly worth more than $1.25.
0 · Reply
eznoeffortgunner
eznoeffortgunner Mar. 17 at 1:07 PM
$STIM womp womp
0 · Reply
Davidoct1405
Davidoct1405 Mar. 17 at 1:07 PM
$STIM such good numbers but poor performance this morning. Seems like it will probably turn around at open. How couldn’t it?
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 12:16 PM
$STIM THINK THIS IS THE PROBLEM?
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 17 at 12:04 PM
$STIM Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.10 up 70.59% YoY • Reported revenue of $41.78M up 85.73% YoY • Neuronetics anticipates operating losses will continue in the near term, but management believes cash and anticipated revenues are sufficient to fund operations for at least the next 12 months; U.S. revenue is expected to increase.
0 · Reply